<http://schema.org/description>
"There&amp;#039;s little doubt that Gilead&amp;#039;s first hepatitis C drug, Sovaldi, is going to be a success. After winning approval in December, Gilead sold $140 million worth of the drug to"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.aol.com/article/2014/02/21/is-gilead-about-to-become-an-oncology-powerhouse/20835248/>